Brief: Janone Selects CPC Clinical Research As Trial Manager For Phase 2B Study Of Jan101
22/07/2021 16:20
July 22 (Reuters) - Janone Inc JAN.O :
* JANONE SELECTS CPC CLINICAL RESEARCH AS TRIAL MANAGER FOR
PHASE
2B STUDY OF JAN101 FOR PERIPHERAL ARTERY DISEASE PATIENTS
Source text for Eikon: ID:nPn71HKxTa
Further company coverage: JAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AI Financial
See all newsBrief: ALT5 Sigma Corporation Restores Compliance With Nasdaq Periodic Filing Requirements
Brief: Alt5 Sigma Expects To File Its Quarterly Report On Form 10-Q
Media: Trump-linked crypto venture Alt5 Sigma retains auditor - FT
Brief: ALT5 Sigma Corporation Provides Corporate Update
American Bitcoin steadies after share lock-up expiry sparks near 40% plunge (updated)